| Identification | Back Directory | [Name]
(±)-1-[(3R*,4R*)-1-(Cyclooctylmethyl)-3-(hydroxymethyl)-4-piperidinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one | [CAS]
217461-40-0 | [Synonyms]
(±)-J 113397
(+/-)-J113397
(±)-1-[(3R*,4R*)-1-(Cyclooctylmethyl)-3-(hydroxymethyl)-4-piperidinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one
2H-Benzimidazol-2-one, 1-[(3R,4R)-1-(cyclooctylmethyl)-3-(hydroxymethyl)-4-piperidinyl]-3-ethyl-1,3-dihydro-, rel- | [Molecular Formula]
C24H37N3O2 | [MDL Number]
MFCD09971098 | [MOL File]
217461-40-0.mol | [Molecular Weight]
399.57 |
| Chemical Properties | Back Directory | [Melting point ]
93-95 °C | [Boiling point ]
518.496±43.00 °C(Press: 760.00 Torr)(predicted) | [density ]
1.110±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | [storage temp. ]
Desiccate at RT | [solubility ]
<19.98mg/ml in DMSO; <19.98mg/ml in ethanol | [form ]
solid | [pka]
14.932±0.10(predicted) | [color ]
White |
| Hazard Information | Back Directory | [Uses]
(+/-)-J 113397 is an analogue is a potent nociceptin/orphanin FQ receptor antagonist. Non-peptide ORL-1 receptor antagonist. | [Biological Activity]
(±)-j 113397 is a potent and selective non-peptidyl antagonist of orl1 receptor, with a ki value of 1.8 nm for cloned human orl1 [1].the orl1 receptor is a g protein-coupled. it is structurally related to the opioid receptors. the heptadecapeptide nociceptin/orphanin fq is the endogenous ligand [2].in cho-orl1 cells, nociceptinr/orphanin fq dose-dependently suppressed the accumulation of cyclic amp stimulated by forskolin with an ec value of 0.22 ± 0.011 nm. treatment with j-113397 at increasing concentration shifted the concentration-response curve of nociceptinr/orphanin fq to the right. data indicated that j-113397 inhibited the interaction between nociceptinr/orphanin fq and orl1 in a competitive manner [1].in a tail-flick test, an i.c.v. injection of nociceptinr/orphanin fq at 0.01-1 nmol or saline was given to mice. i.c.v. injection of saline did not obviously change the latency of tail-flick. nociceptinr/orphanin fq at doses of more than 0.1 nmol shortened the latency. at the high concentration, the effect of nociceptinr/orphanin fq reached a maximal decrease at 15 min after the injection of j-113397. the effect of nociceptinr/orphanin fq lasted for more than 60 min. j-113397 inhibited the shortening of mouse tail-flick latency induced by nociceptinr/orphanin fq dose-dependently. j-113397 at 30 mg/kg completely reversed the hyperalgesia elicited by nociceptinr/orphanin fq [1]. | [IC 50]
NOP Receptor/ORL1 | [storage]
Desiccate at RT | [References]
[1]. ozaki s, kawamoto h, itoh y, et al. in vitro and in vivo pharmacological characterization of j-113397, a potent and selective non-peptidyl orl1 receptor antagonist. european journal of pharmacology, 2000, 402(1): 45-53.
[2]. mollereau c, mouledous l. tissue distribution of the opioid receptor-like (orl1) receptor. peptides, 2000, 21(7): 907-917. |
|
| Company Name: |
Energy Chemical
|
| Telephone: |
400-0056266 |
| Website: |
www.energy-chemical.com |
|